JP2007524708A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007524708A5 JP2007524708A5 JP2007500287A JP2007500287A JP2007524708A5 JP 2007524708 A5 JP2007524708 A5 JP 2007524708A5 JP 2007500287 A JP2007500287 A JP 2007500287A JP 2007500287 A JP2007500287 A JP 2007500287A JP 2007524708 A5 JP2007524708 A5 JP 2007524708A5
- Authority
- JP
- Japan
- Prior art keywords
- lactalbumin
- bioactive
- variant
- complex
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0404369A GB0404369D0 (en) | 2004-02-26 | 2004-02-26 | Novel therapies |
| GB0404339A GB0404339D0 (en) | 2004-02-26 | 2004-02-26 | Therapeutic treatment |
| GB0404358A GB0404358D0 (en) | 2004-02-26 | 2004-02-26 | Therapeutic treatment |
| PCT/GB2005/000685 WO2005082406A1 (en) | 2004-02-26 | 2005-02-24 | Lactalbumin for inhibiting angiogenesis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007524708A JP2007524708A (ja) | 2007-08-30 |
| JP2007524708A5 true JP2007524708A5 (cg-RX-API-DMAC10.html) | 2008-03-21 |
Family
ID=34915949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007500287A Pending JP2007524708A (ja) | 2004-02-26 | 2005-02-24 | 血管新生を阻害するラクトアルブミン |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20080039381A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1727561A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2007524708A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2005082406A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0210464D0 (en) * | 2002-05-08 | 2002-06-12 | Svanborg Catharina | Therapeutic treatment |
| WO2008138348A1 (en) * | 2007-05-09 | 2008-11-20 | Nya Hamlet Pharma Ab | Preparation of complexed lactalbumin |
| US20100112702A1 (en) * | 2008-02-25 | 2010-05-06 | Klein Benjamin Y | Method designed to divert glucose away from the glycolytic pathway |
| WO2009135494A2 (en) * | 2008-05-09 | 2009-11-12 | Nya Hamlet Pharma Ab | Alpha-lactalbumin composition for the treatment of actinic keratosis |
| WO2010131237A1 (en) * | 2009-05-13 | 2010-11-18 | Agriculture And Food Development Authority (Teagasc) | A process for producing a biologically active globular protein complex |
| WO2014023976A1 (en) * | 2012-08-09 | 2014-02-13 | Hamlet Pharma Ab | Prophylactic and nutraceutical therapy |
| WO2024075003A1 (en) | 2022-10-03 | 2024-04-11 | Linnane Pharma Ab | A complex comprising a alpha-lactalbumin and a fatty acid or lipid for use in the treatment or prevention of cancer |
| GB202303177D0 (en) | 2023-03-03 | 2023-04-19 | Linnane Pharma Ab | Method of predicting response to treatment |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2188903A (en) * | 1938-12-03 | 1940-02-06 | Dow Chemical Co | Polystyrene compositions |
| GB9725126D0 (en) * | 1997-11-27 | 1998-01-28 | Svanborg Catharina | Therapeutic agents |
| GB0205347D0 (en) * | 2002-03-07 | 2002-04-24 | Svanborg Catharina | Biologically active complex |
| GB0210464D0 (en) * | 2002-05-08 | 2002-06-12 | Svanborg Catharina | Therapeutic treatment |
| GB0211658D0 (en) * | 2002-05-22 | 2002-07-03 | Svanborg Catharina | Novel therapies and methods of screening for therapeutic compounds |
-
2005
- 2005-02-24 WO PCT/GB2005/000685 patent/WO2005082406A1/en not_active Ceased
- 2005-02-24 EP EP05708451A patent/EP1727561A1/en not_active Withdrawn
- 2005-02-24 JP JP2007500287A patent/JP2007524708A/ja active Pending
- 2005-02-24 US US10/590,938 patent/US20080039381A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhao et al. | Molecular hydrogels of therapeutic agents | |
| US20190023743A1 (en) | Methods and compositions for modulating drug-polymer architecture, pharmacokinetics and biodistribution | |
| ES2806989T3 (es) | Péptidos antiinflamatorios, y usos de los mismos | |
| Tung et al. | Bovine lactoferrin inhibits lung cancer growth through suppression of both inflammation and expression of vascular endothelial growth factor | |
| US20080275120A1 (en) | Leucine rich composition | |
| WO2001027079A3 (en) | Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease | |
| US20230158100A1 (en) | Treatment of panx1 associates diseases | |
| Ahmed et al. | Therapeutic potential of marine peptides in glioblastoma: Mechanistic insights | |
| WO2001062799A3 (en) | Method for inhibiting angiogenesis using molecules that enhance plasmin activity | |
| US20210353757A1 (en) | Nanobody preparation system for administration through internal and external epidermis of head and neck and preparation method and use | |
| WO2000078327A3 (de) | Mittel zur behandlung maligner erkrankungen unter verwendung von e1a-defizienten adenoviren mit yb-1 abhängiger replikation | |
| JP2005530703A5 (cg-RX-API-DMAC10.html) | ||
| JP2006500321A5 (cg-RX-API-DMAC10.html) | ||
| EA200301295A1 (ru) | Полипептид, его конъюгат с доксорубицином и фармацевтическая композиция на его основе | |
| ES2964145T3 (es) | Método para producir un hidrolizado de proteína de cerebro de mamífero | |
| Miwa et al. | Inhibition of tumor cell growth by protein factors derived from the developing mouse brain | |
| KR20070087267A (ko) | 타이로신-세린-발린(ysv)을 포함하는 생물학적 활성펩티드 | |
| KR20130116374A (ko) | 예방적 또는 치료적 형태로 투여된 α-MSH를 사용하여 개선시킬 수 있는 다양한 병리 과정을 치료하기 위한 니코틴, 그의 유사체, 그의 전구체 또는 그의 유도체의 용도 | |
| KR20200010209A (ko) | Clpb로부터 유래된 단백질 및 그의 용도 | |
| ES2968843T3 (es) | Molécula de ARNm y agente fotosensibilizador para uso médico | |
| JP2022545429A (ja) | がん治療のための化学療法剤とα-ラクトグロブリン-オレイン酸複合体との組合せ | |
| JP4689664B2 (ja) | 生物学的に活性なペプチドvapeehptllteaplnpk誘導体 | |
| JP2007533728A5 (cg-RX-API-DMAC10.html) | ||
| CN105477628B (zh) | 抗癌组合物及其用途 | |
| CN115803045A (zh) | 用于增强放射治疗的包括含有il-2蛋白和cd80蛋白的融合蛋白的药物组合物 |